Wellnex Life Ltd (AU:WNX) has released an update.
Wellnex Life Limited reported a strong first quarter in fiscal year 2025 with record brand sales cash inflows of $4.1 million, contributing to a total cash receipt of $5.2 million, marking a 23% increase from the previous year. The company is expanding globally with its first orders for the UK market and has launched a new medicinal cannabis brand, Wellness Life, for the Australian market. Wellnex is also progressing towards a dual listing on the London Stock Exchange, further supported by a successful placement with UK investors.
For further insights into AU:WNX stock, check out TipRanks’ Stock Analysis page.
